Clinical trial

6R-BH4 Pulmonary Arterial Hypertension Study

NCT00435331

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE1

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2013-06-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Interventions

sapropterin dihydrochloride (6R-BH4)DRUG

Sponsors & collaborators

Vanderbilt Universitylead sponsor

National Institutes of Health (NIH)collaborator

BioMarin Pharmaceuticalcollaborator

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00435331 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.